Form 4 for SNWV SANUWAVE Health, Inc.
Accepted 2026-04-21 18:17:43 ET · period of report 2026-04-17 · accession 0001493152-26-018387 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2026-04-21 18:17 | 2026-04-17+ | SNWV | Opaleye Management Inc. | 10% | S - Sale | $20.46 | -16.5K | 954.8K | -2% | -$337.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, par value $0.001 per share | 2026-04-17 | S | D | 11,267 | $20.46 | 955,000 | I By Opaleye, L.P. | — | — | (F3) The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $20.17-$21.00 inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price. (F1) Represents securities owned directly by Opaleye, L.P. (the "Fund"). As the investment manager of the Fund, Opaleye Management Inc. may be deemed to beneficially own the securities owned directly by the Fund. (F4) Opaleye Management Inc. disclaims beneficial ownership of the shares reported herein except to the extent of its pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that Opaleye Management Inc. is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended, or for any other purpose. |
| 2 | Common | Common Stock, par value $0.001 per share | 2026-04-17 | S | D | 5,000 | $20.46 | 10,000 | I By Managed account | — | — | (F3) The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $20.17-$21.00 inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price. (F2) Securities owned by a separately managed account (the "Managed Account"). As the portfolio manager of the Managed Account, Opaleye may be deemed to beneficially own the securities owned directly by the Managed Account. (F4) Opaleye Management Inc. disclaims beneficial ownership of the shares reported herein except to the extent of its pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that Opaleye Management Inc. is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended, or for any other purpose. |
| 3 | Common | Common Stock, par value $0.001 per share | 2026-04-21 | S | D | 202 | $20.50 | 954,798 | I By Opaleye, L.P. | — | — | (F1) Represents securities owned directly by Opaleye, L.P. (the "Fund"). As the investment manager of the Fund, Opaleye Management Inc. may be deemed to beneficially own the securities owned directly by the Fund. (F4) Opaleye Management Inc. disclaims beneficial ownership of the shares reported herein except to the extent of its pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that Opaleye Management Inc. is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended, or for any other purpose. |